Home

BCR-ABL

31.1.2011

http://www.physorg.com/news/2011-01-southampton-scientists-patient-trials-leukemia.html
Southampton scientists begin patient trials of new leukemia cancer vaccine
DNA-vaccine, BCR-ABL, chronic myeloid leukaemia, AML, tyrosine kinase inhibitors

12.9.2011

http://www.eurekalert.org/pub_releases/2011-09/iuso-cdm090811.php
Cardiovascular drug may offer new treatment for some difficult types of leukemia
Rho kinase, or ROCK, KIT, FLT3, BCR-ABL, ROCK inhibitor, Fasudil, acute myelogenous leukemia

13.12.2010

http://www.eurekalert.org/pub_releases/2010-12/joci-nan120910.php
New approaches needed for treating chronic myeloid leukemia
Chronic myeloid leukemia (CML), BCR-ABL

17.6.2007

http://www.eurekalert.org/pub_releases/2007-06/ka-cap060807.php
ChemGenex announces publication confirming activity of Ceflatonin in T315I-Positive CML
chronic myeloid leukemia (CML), T315I Bcr-Abl mutation, Ceflatonin (homoharringtonine, HHT), Ceflatonin (homoharringtonine, HHT) Gleevec-resistant, CML, T315I Bcr-Abl mutation

31.8.2007

http://www.eurekalert.org/pub_releases/2007-08/sjcr-sjf082907.php
St. Jude finds factors that accelerate resistance to targeted therapy in lymphoblastic leukemia
Gleevec BCR-ABL CML A-L-L

31.5.2010

http://www.eurekalert.org/pub_releases/2010-05/cp-ctt051010.php
Combination therapy targets stubborn leukemia stem cells
stubborn BCR-ABL oncoprotein, CML

31.1.2008

http://idw-online.de/pages/de/news244358
Nur wer den Feind kennt, kann ihn bekämpfen
ABL BCR Merkelzellkarzinom BCR-ABL Imatinib

7.10.2008

http://www.jci.org/articles/view/33337
Ablation of PI3K blocks BCR-ABL leukemogenesis in mice, and a dual PI3K/mTOR inhibitor prevents expansion of human BCR-ABL+ leukemia cells
mTOR, chronic myelogenous leukemia

31.8.2007

http://www.eurekalert.org/pub_releases/2007-08/cshl-goi082707.php
Genetics of imatinib resistance in acute lymphoblastic leukemia
BCR-ABL

31.8.2007

http://www.eurekalert.org/pub_releases/2007-08/joci-nwt081607.php
New weapon to fight leukemia
FTY720 BCR-ABL A-L-L CML-BC, treatment of multiple sclerosis

14.6.2011

http://medicalxpress.com/news/2011-06-efficient-therapy-specific-leukemia.html
Toward a more efficient therapy for a specific form of leukemia
imatinib, CML, placental growth factor (PlGF), BCR-ABL1 fusion kinase, antibodies against PlGF (antiPlGF)

14.6.2011

http://www.eurekalert.org/pub_releases/2011-06/vfi-tam061411.php
Toward a more efficient therapy for a specific form of leukemia
imatinib, CML, placental growth factor (PlGF), BCR-ABL1 fusion kinase, antibodies against PlGF (antiPlGF)

30.11.2010

http://www.physorg.com/news/2010-11-tiny-rna-shown-multiple-leukemia.html
Tiny RNA shown to cause multiple types of leukemia
microRNA 125b (miR-125b), BCR-ABL mutation

25.3.2011

http://www.eurekalert.org/pub_releases/2011-03/uoc--uc032411.php
UCLA's cancer 'roadmap' could help combat resistance to targeted drug therapies
Bcr-Abl mutation, leukemias, Gleevec

5.2.2009

http://idw-online.de/pages/de/news299462
Leukämie: Suche nach molekular-gezielten Therapieansätzen
Leukämie, PIM Proteinkinasen, PIM1, PIM2, chronisch myeloische Leukämie (CML), RNA-Interferenz, ABL

6.5.2007

http://www.eurekalert.org/pub_releases/2007-05/jotn-ls042607.php
Unstable leukemia stem cells may predispose patients to drug resistance
BCR-ABL gene, chronic myeloid leukemia stem cells

13.4.2011

http://www.eurekalert.org/pub_releases/2011-04/tmc-nds041111.php
New drug shows potential for treatment-resistant leukemia
DCC-2036, CML, BCR-ABL1

12.4.2011

http://www.physorg.com/news/2011-04-drug-potential-treatment-resistant-leukemia.html
New drug shows potential for treatment-resistant leukemia
DCC-2036, CML, BCR-ABL1

20.4.2009

http://derstandard.at/?id=1237229895722
Forscher finden neuen Ansatzpunkt für Leukämie-Behandlung
Bcr-Abl, Giulio Superti-Furga

3.3.2010

http://www.eurekalert.org/pub_releases/2010-03/w-tlc030310.php
Targeting leukemia cell's gene 'addiction' presents new strategy for treatment
Stat5 Stat3 Bcr/Abl-induced leukaemia growth, CML, A-L-L, Imatinib, Non-oncogene addiction' (NOA)

30.10.2004

http://www.eurekalert.org/pub_releases/2004-10/uopm-gto102904.php
Gene-silencing technique offers new way to fight drug-resistant leukemia
Gen, Silencing, BCR-ABL1 protein, Leukämie

16.12.2010

http://www.eurekalert.org/pub_releases/2010-12/dumc-btc121610.php
Blocking the critical structure that lets cancer cells move -- their feet
Abl family of protein kinases, Arg, invadopodia, MMP, Imatinib